Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025
Kiniksa Pharmaceuticals (Nasdaq: KNSA) will report third quarter 2025 results and recent portfolio execution on Tuesday, October 28, 2025 at 8:30 a.m. ET. The company will host a conference call and live webcast accessible via the Investors & Media section of www.kiniksa.com.
Participants can register to join by telephone and will receive a confirmation email with dial-in details, a unique passcode, and registrant ID. A replay will be available on Kiniksa’s website approximately 48 hours after the event.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) riporterà risultati del terzo trimestre 2025 e l'esecuzione recente del portafoglio il martedì 28 ottobre 2025 alle 8:30 (ET). L'azienda ospiterà una conference call e una webcast in diretta accessibili tramite la sezione Investitori e Media di www.kiniksa.com.
I partecipanti possono registrarsi per partecipare telefonicamente e riceveranno un'email di conferma con i dettagli per il dial-in, un codice di accesso univoco e l'ID del registrante. Una riproduzione sarà disponibile sul sito di Kiniksa circa 48 ore dopo l'evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) informará los resultados del tercer trimestre de 2025 y la reciente ejecución de la cartera el martes 28 de octubre de 2025 a las 8:30 a.m. ET. La empresa organizará una llamada de conferencia y una transmisión en directo accesibles desde la sección de Inversores y Medios de www.kiniksa.com.
Los participantes pueden registrarse para unirse por teléfono y recibirán un correo de confirmación con los detalles de marcación, un código de acceso único y el ID de registrante. Una repetición estará disponible en el sitio Web de Kiniksa aproximadamente 48 horas después del evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA)는 2025년 3분기 실적과 포트폴리오의 최근 실행을 2025년 10월 28일 화요일 오전 8시 30분(동부 표준시)에 발표합니다. 회사는 www.kiniksa.com의 투자자 및 언론 섹션에서 접근 가능한 컨퍼런스 콜 및 라이브 웹캐스트를 주최합니다.
참가자는 전화로 참여하기 위해 등록할 수 있으며 다이얼 인 세부 정보, 고유 패스코드 및 등록자 ID가 포함된 확인 이메일을 받게 됩니다. 이벤트 후 약 48시간 이내에 Kiniksa의 웹사이트에서 재방송을 이용할 수 있습니다.
Kiniksa Pharmaceuticals (Nasdaq : KNSA) publiera les résultats du troisième trimestre 2025 et la récente exécution du portefeuille le mardi 28 octobre 2025 à 8 h 30 HE. L'entreprise organisera une conférence téléphonique et une webdiffusion en direct accessibles via la section Investisseurs & Médias de www.kiniksa.com.
Les participants peuvent s'inscrire pour participer par téléphone et recevront un e-mail de confirmation avec les détails d'accès, un code d'accès unique et l'ID d'enregistrement. Une rediffusion sera disponible sur le site Web de Kiniksa environ 48 heures après l'événement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) wird die Ergebnisse des dritten Quartals 2025 und die jüngste Portfolioumsetzung am Dienstag, 28. Oktober 2025 um 08:30 Uhr ET melden. Das Unternehmen wird eine Telefonkonferenz und einen Live-Webcast anbieten, zugänglich über den Bereich Investors & Media von www.kiniksa.com.
Teilnehmer können sich telefonisch registrieren und erhalten eine Bestätigungs-E-Mail mit Dial-in-Details, einem eindeutigen Passcode und einer Registrant ID. Eine Wiedergabe wird auf der Website von Kiniksa etwa 48 Stunden nach der Veranstaltung verfügbar sein.
كينيكسا للأدوية (ناسداك: KNSA) ستعلن عن نتائج الربع الثالث من 2025 وتنفيذ المحفظة الأخير في الثلاثاء 28 أكتوبر 2025 الساعة 8:30 صباحاً بتوقيت شرق الولايات المتحدة. ستستضيف الشركة مكالمة هاتفية وبثاً مباشراً عبر الويب يمكن الوصول إليه من خلال قسم المستثمرين ووسائل الإعلام في www.kiniksa.com.
يمكن للمشاركين التسجيل للانضمام عبر الهاتف وسيستلمون رسالة تأكيد تحتوي على تفاصيل الاتصال الهاتفي، ورمز وصول فريد، ومعرّف المُسجّل. سيكون هناك إعادة بث متاح على موقع كينكيسا الإلكتروني تقريباً خلال 48 ساعة من الحدث.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) 将在2025年第三季度业绩及最近的产品组合执行方面于2025年10月28日星期二东部时间上午8:30公布。公司将主持一个电话会议和实时网络广播，您可通过www.kiniksa.com的投资者与媒体页面访问。
参与者可以注册以电话方式加入，并将收到一封确认邮件，其中包含拨入详情、唯一访问码和注册人ID。活动结束后大约48小时后，Kiniksa的网站将提供回放。
- None.
- None.
LONDON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 28, 2025 at 8:30 a.m. Eastern Time to report its third quarter 2025 financial results and recent portfolio execution.
A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
FAQ
When will Kiniksa (KNSA) report third quarter 2025 financial results?
How can investors access the Kiniksa (KNSA) Q3 2025 webcast?
How do I join Kiniksa's (KNSA) conference call by phone for October 28, 2025?
Will Kiniksa (KNSA) provide a replay of the Q3 2025 earnings call?
What topics will Kiniksa (KNSA) cover on the October 28, 2025 call?
